United States· US:71782-141_45147abc-c3c3-c377-e063-6394a90a954d
CANNON BALM 140
A medicinal product containing octinoxate; avobenzone; octisalate; oxybenzone; octocrylene, registered in United States by DUKE CANNON SUPPLY CO..
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- OCTINOXATE; AVOBENZONE; OCTISALATE; OXYBENZONE; OCTOCRYLENE
- Manufacturer
- DUKE CANNON SUPPLY CO.
- Country
- United States (US)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 2
- ndc11717821410117 g in 1 TUBE (71782-141-01)
- ndc1171782-141-01
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/4f444902-fb48-49a8-b060-2f567cace5c4 GET /v1/drugs/4f444902-fb48-49a8-b060-2f567cace5c4?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "TOPICAL",
"source": "ndc",
"strength": "1.28; .51; .85; 1.02; .85",
"substance": "OCTINOXATE; AVOBENZONE; OCTISALATE; OXYBENZONE; OCTOCRYLENE",
"productndc": "71782-141",
"dosage_form": "STICK",
"dea_schedule": null,
"strength_unit": "g/17g; g/17g; g/17g; g/17g; g/17g",
"application_number": "M020",
"marketing_category": "OTC MONOGRAPH DRUG"
}See everything about octinoxate; avobenzone; octisalate; oxybenzone; octocrylene.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.